Montauk Renewables (MNTK) Q1 2026 earnings summary
Event summary combining transcript, slides, and related documents.
Q1 2026 earnings summary
7 May, 2026Executive summary
Revenues reached $46.4 million in Q1 2026, up 9% year-over-year, driven by increased RINs sold and GreenWave joint venture contributions.
Adjusted EBITDA rose 22.8% to $10.8 million, while EBITDA increased to $9.4 million.
Net income was $5,000, reversing a net loss of $0.5 million in Q1 2025, though some reports show a $0.3 million net loss due to higher operating expenses.
Commissioned Montauk Ag Renewables project in North Carolina, with syngas production underway and revenue generation expected to begin in May 2026.
Signed a five-year extension for Raeger Gas Rights, securing feedstock supply through 2031.
Financial highlights
Q1 2026 total revenues were $46.4 million, up 9% year-over-year from $42.6 million.
Adjusted EBITDA was $10.8 million, up from $8.8 million in Q1 2025.
Operating loss was $1.6 million, compared to operating income of $0.4 million a year ago, due to higher operating and maintenance expenses.
Cash and cash equivalents at quarter-end were $25.9 million.
Net cash provided by operating activities was $15.8 million, up from $9.1 million in Q1 2025.
Outlook and guidance
2026 RNG production guidance reaffirmed at 5.8–6 million MMBtu, with revenue expected between $175–$190 million.
Renewable electricity production guidance: 195,000–207,000 MWh, revenue $33–$37 million.
Ongoing development projects include Bowerman RNG, Tulsa RNG, Rumpke RNG Relocation, and Atascocita LCO2, with capital expenditures for 2026 development projects estimated at $80–$100 million.
Guidance reflects a one-month delay in Montauk Ag Renewables revenue start due to commissioning timing.
Latest events from Montauk Renewables
- Director elections, auditor ratification, and strategic growth initiatives headline the annual meeting.MNTK
Proxy filing10 Apr 2026 - Vote on two director nominees and auditor ratification at the May 2026 virtual Annual Meeting.MNTK
Proxy filing10 Apr 2026 - Net income plunged on flat revenue as RIN prices fell, but 2026 guidance expects growth.MNTK
Q4 202512 Mar 2026 - Q2 revenue dropped 18.6% on delayed RIN sales, but 2024 guidance and project pipeline remain strong.MNTK
Q2 20241 Feb 2026 - Q3 2024 revenue up 18.4% and net income up 31.8%, but project delays persist.MNTK
Q3 202414 Jan 2026 - Net income fell 34.9% to $9.7M on flat revenue, with 2025 RNG revenue guidance at $150–$170M.MNTK
Q4 202426 Dec 2025 - Director elections, auditor ratification, and strategic growth initiatives highlight the 2025 meeting.MNTK
Proxy Filing1 Dec 2025 - Shareholders to elect two directors and ratify Grant Thornton LLP as auditor at the annual meeting.MNTK
Proxy Filing1 Dec 2025 - Revenue up 9.8%, but net loss and regulatory delays challenge outlook; major capex planned.MNTK
Q1 202526 Nov 2025